Operation optimization
Thomson Scientific
March 2007
In response to new requirements, life sciences companies around the world are rethinking their regulatory activities, creating new opportunities for operational excellence. In this article — originally published in the February/March 2007 edition of Pharmaceutical Executive Europe — Jim Nichols explores some of the new concepts that are making a difference.
Introduction
Due to new and emerging regulatory requirements, companies are looking to streamline regulatory affairs and operations, improving in areas such as reducing time spent in preparing and reviewing content for submissions and updates. This is because official document versions can be identified with confidence and then re-used without extensive or additional review cycles . . .
Read the full article (PDF)